Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P4HB | P07237 | 5/20 | 0.69 |
| ▸ | AKR1B1 | P15121 | 4/20 | 0.69 |
| ▸ | CA12 | O43570 | 2/20 | 0.69 |
| ▸ | CA2 | P00918 | 2/20 | 0.69 |
| ▸ | CA4 | P22748 | 2/20 | 0.69 |
| ▸ | CA7 | P43166 | 2/20 | 0.69 |
| ▸ | ACHE | P22303 | 1/20 | 0.69 |
| ▸ | RPS6KA3 | P51812 | 3/20 | 0.63 |
| ▸ | EPHX2 | P34913 | 5/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.61 |
| ▸ | GAA | P10253 | 4/20 | 0.61 |
| ▸ | POLB | P06746 | 3/20 | 0.61 |
| ▸ | APEX1 | P27695 | 1/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.60 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.60 |
| ▸ | KDM1A | O60341 | 1/20 | 0.60 |
| ▸ | SLCO2B1 | O94956 | 1/20 | 0.60 |
| ▸ | ALPL | P05186 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6903921 | 0.88 | NQO2 (0.70) | P4HBAKR1B1CA12CA2CA4 | |
| SCHEMBL27193647 | 0.88 | P4HB (0.87) | P4HBAKR1B1CA12CA2CA4 | |
| SCHEMBL29453024 | 0.88 | P4HB (0.87) | P4HBAKR1B1CA12CA2CA4 | |
| SCHEMBL4391457 | 0.88 | P4HB (0.87) | P4HBAKR1B1CA12CA2CA4 | |
| SCHEMBL31173775 | 0.88 | P4HB (0.87) | P4HBAKR1B1CA12CA2CA4 | |
| SCHEMBL30217565 | 0.88 | P4HB (0.87) | P4HBAKR1B1CA12CA2CA4 | |
| SCHEMBL9993788 | 0.88 | P4HB (0.87) | P4HBAKR1B1CA12CA2CA4 | |
| SCHEMBL10379812 | 0.87 | MAOA (0.53) | P4HBAKR1B1CA12CA2CA4 | |
| SCHEMBL31720497 | 0.85 | P4HB (0.79) | P4HBAKR1B1CA12CA2CA4 | |
| SCHEMBL9993267 | 0.85 | P4HB (0.79) | P4HBAKR1B1CA12CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250339399-A1 | SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM | BEIJING CREATRON INSTITUTE OF PHARMACEUTICAL RES CO LTD (CN) | 2025-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250339399-A1 | SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM | S100A8, TP53, AQP1 | P4HB 1151/4885AKR1B1 2311/4885CA12 50/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.